These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31646005)

  • 1. Erratum: Author Correction: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity.
    Tian H; Shi G; Wang Q; Li Y; Yang Q; Li C; Yang G; Wu M; Xie Q; Zhang S; Yang Y; Xiang R; Yu D; Wei Y; Deng H
    Signal Transduct Target Ther; 2019; 4():31. PubMed ID: 31646005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 Blockade Overcomes Adaptive Immune Resistance in Treatment with Anchored-GM-CSF Bladder Cancer Cells Vaccine.
    Zhang X; Shi X; Li J; Mo L; Hu Z; Gao J; Wu S; Long Z
    J Cancer; 2018; 9(23):4374-4381. PubMed ID: 30519342
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum: Author Correction: Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis.
    Than A; Xu S; Li R; Leow MK; Sun L; Chen P
    Signal Transduct Target Ther; 2018; 3():10. PubMed ID: 29683137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Tim-3 expression on TILs during treatment with the Anchored GM-CSF vaccine and anti-PD-1 antibodies is inversely correlated with response in prostate cancer.
    Zhang X; Chen H; Li G; Zhou X; Shi Y; Zou F; Chen Y; Gao J; Yang S; Wu S; Long Z
    J Cancer; 2020; 11(3):648-656. PubMed ID: 31942188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer.
    Shi X; Zhang X; Li J; Zhao H; Mo L; Shi X; Hu Z; Gao J; Tan W
    Cancer Lett; 2017 Oct; 406():27-35. PubMed ID: 28797844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.
    Yoon HA; Aleyas AG; George JA; Park SO; Han YW; Lee JH; Cho JG; Eo SK
    Microbiol Immunol; 2006; 50(2):83-92. PubMed ID: 16490926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
    He SB; Sun K; Wang L; Li DC; Zhang YY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
    Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Author Correction: Induction of Mucosal Humoral Immunity by Subcutaneous Injection of an Oil-emulsion Vaccine against
    Ishida Y; Sakai E; Sato K; Sugiyama E; Mima K; Taneno A; Shimomura H; Cui L; Hirai Y
    Food Saf (Tokyo); 2019 Jun; 7(2):58-59. PubMed ID: 31999277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Author Correction: Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females.
    Potluri T; Fink AL; Sylvia KE; Dhakal S; Vermillion MS; Vom Steeg L; Deshpande S; Narasimhan H; Klein SL
    NPJ Vaccines; 2019; 4():35. PubMed ID: 31428462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Shi X; Zhang X; Li J; Mo L; Zhao H; Zhu Y; Hu Z; Gao J; Tan W
    Int J Cancer; 2018 May; 142(10):2106-2117. PubMed ID: 29243219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Author Correction: Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach.
    Leasi F; Sevigny JL; Laflamme EM; Artois T; Curini-Galletti M; de Jesus Navarrete A; Di Domenico M; Goetz F; Hall JA; Hochberg R; Jörger KM; Jondelius U; Todaro MA; Wirshing HH; Norenburg JL; Thomas WK
    Commun Biol; 2018; 1():237. PubMed ID: 30588516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction.
    Abe J; Wakimoto H; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
    J Cancer Res Clin Oncol; 1995; 121(9-10):587-92. PubMed ID: 7559742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
    Dela Cruz JS; Trinh KR; Morrison SL; Penichet ML
    J Immunol; 2000 Nov; 165(9):5112-21. PubMed ID: 11046042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing
    Zhang W; Pan X; Xu Y; Guo H; Zheng M; Chen X; Wu H; Luan F; He Q; Ding L; Yang B
    Acta Pharm Sin B; 2023 Oct; 13(10):4337. PubMed ID: 37799392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral GM-CSF Gene Transduction into Breast Cancer Cells Induced Long-Lasting Antitumor Immunity in Mice.
    Ogawa T; Kusumoto M; Mizumoto K; Sato N; Tanaka M
    Breast Cancer; 1999 Oct; 6(4):301-304. PubMed ID: 11091734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
    Zhang X; Shi X; Li J; Hu Z; Zhou D; Gao J; Tan W
    J Urol; 2012 Mar; 187(3):1071-9. PubMed ID: 22266013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sargramostim (rhGM-CSF) as immunotherapy.
    Waller EK
    Oncologist; 2007; 12 Suppl 2():22-6. PubMed ID: 18039636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.